Loading...
XMAD
ECR
Market cap352mUSD
Dec 04, Last price  
3.31EUR
1D
0.30%
1Q
19.06%
Jan 2017
79.89%
Name

Ercros SA

Chart & Performance

D1W1MN
XMAD:ECR chart
P/E
P/S
0.45
EPS
Div Yield, %
2.90%
Shrs. gr., 5y
-2.94%
Rev. gr., 5y
-0.07%
Revenues
667m
-7.98%
432,800,000774,410,000870,090,000866,490,000612,540,000609,280,000686,040,000677,530,000624,970,000603,670,000618,270,000602,540,000685,970,000671,940,000669,782,000568,797,000800,055,000998,532,000725,294,000667,415,000
Net income
-12m
L
38,500,0004,850,000-33,510,000-20,302,000,000-49,820,000-12,470,000-900,000-12,130,000-3,750,000-6,290,0007,240,00045,160,00044,582,00044,876,00031,043,0006,257,00043,297,00062,989,00027,585,000-11,657,000
CFO
10m
-81.40%
-650,000-14,540,00031,620,000-680,000,00040,910,000-10,580,00011,520,00019,170,00023,860,00028,050,00014,000,00038,950,00043,813,00044,876,00059,431,00074,591,00060,324,00062,989,00051,140,0009,514,000
Dividend
Jul 08, 20240.096 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers. This segment's products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; to produce compound feed and in cooling equipment. The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding powders, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing chipboards, and decorative laminates and plywoods, as well as resins, paints, and varnishes in the furniture and decoration industry; plugs and switches in the electrical components sector; and household, sanitary, and packaging materials in the textile tanning industry. The Pharmacy division engages in the production of raw materials and intermediate products from antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal agents. This segment's products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, calcium and sodium fosfomycin, fosfomycin trometamol, and fusidic acid. The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.
IPO date
Sep 17, 1990
Employees
1,343
Domiciled in
ES
Incorporated in
ES

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT